{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03076",
      "entity_text" : "VEGFR inhibitor",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04568",
      "entity_text" : "Anti-PlGF",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Anti-PlGF activity enhancing VEGFR inhibitor therapy should reduce the release of angiogenic factors by tumour and vascular cells (XREF_FIG).",
  "reading_complete" : "2020-08-08T12:39:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:34:09Z",
  "trigger" : "enhancing",
  "evidence" : [ "Anti-PlGF activity enhancing VEGFR inhibitor" ],
  "pmc_id" : "4130202",
  "score" : 0
}